Inovio Pharmaceuticals
INO
#9149
Rank
S$0.14 B
Marketcap
S$2.12
Share price
0.90%
Change (1 day)
-18.65%
Change (1 year)

Inovio Pharmaceuticals (INO) - Cash on Hand

Cash on Hand as of September 2025 : S$64.28 Million

According to Inovio Pharmaceuticals's latest financial reports the company has S$64.28 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Inovio Pharmaceuticals - Cash on Hand chart (from 1998 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31S$0.12 B-33.33%
2023-12-31S$0.19 B-43.42%
2022-12-31S$0.33 B-37.48%
2021-12-31S$0.54 B-0.37%
2020-12-31S$0.54 B351.15%
2019-12-31S$0.12 B8.77%
2018-12-31S$0.11 B-34.89%
2017-12-31S$0.17 B12.4%
2016-12-31S$0.15 B-34.23%
2015-12-31S$0.23 B86.38%
2014-12-31S$0.12 B85.53%
2013-12-31S$66.67 M298.55%
2012-12-31S$16.72 M-57.24%
2011-12-31S$39.12 M39.05%
2010-12-31S$28.13 M-54.28%
2009-12-31S$61.54 M204.89%
2008-12-31S$20.18 M-48.52%
2007-12-31S$39.21 M11.08%
2006-12-31S$35.3 M23.51%
2005-12-31S$28.58 M-2.07%
2004-12-31S$29.18 M27.62%
2003-12-31S$22.86 M1405.52%
2002-12-31S$1.51 M-54.74%
2001-12-31S$3.35 M
2001-03-31S$11.85 M-29.21%
2000-03-31S$16.74 M56.33%
1999-03-31S$10.7 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
S$23.48 B 36,437.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$14.59 B 22,601.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$18.95 B 29,394.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$9.29 B 14,365.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$23.04 B 35,752.07%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$5.62 B 8,648.23%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cleveland BioLabs
CBLI
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
S$1.15 B 1,704.24%๐Ÿ‡บ๐Ÿ‡ธ USA